COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1909: Articles 19081-19090  | Next

An effect of the COVID-19 pandemic: significantly more complicated appendicitis due to delayed presentation of patients!
Burgard, M., Cherbanyk, F., Nassiopoulos, K., Malekzadeh, S., Pugin, F., Egger, B.
10.1101/2021.01.23.21250358 — Posted: 2021-01-25
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Wu, K., Werner, A. P., Moliva, J. I., Koch, M., Choi, A., Stewart-Jones, G. B. E., Bennett, H., Boyoglu-Barnum, S., Shi, W., Graham, B. S., Carfi, A., Corbett, K. S., Seder, R. A., Edwards, D. K.
10.1101/2021.01.25.427948 — Posted: 2021-01-25 Discussion: Offsite
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
Reuschl, A.-K., Thorne, L., Zuliani Alvarez, L., Bouhaddou, M., Obernier, K., Soucheray, M., Turner, J., Fabius, J., Nguyen, G. T., Swaney, D., Rosales, R., White, K. M., Aviles, P., Kirby, I. T., Melnyk, J. E., Shi, Y., Zhang, Z., Shokat, K., Garcia-Sastre, A., Jolly, C., Towers, G. J., Krogan, N. J.
10.1101/2021.01.24.427991 — Posted: 2021-01-24
Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., Harrison, P. J.
10.1101/2021.01.16.21249950 — Posted: 2021-01-24 Discussion: Onsite | Offsite
An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19
Wang, J. Y., Zhang, W., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.01.24.427965 — Posted: 2021-01-24
Meta-analysis reveals consistent immune response patterns in COVID-19 infected patients at single-cell resolution
Garg, M., Li, X., Moreno Cortez, P. A., Papatheodorou, I., Shu, Y., Brazma, A., Miao, Z.
10.1101/2021.01.24.427089 — Posted: 2021-01-24
Variation analysis of SARS-CoV-2 complete sequences from Iran
Moradi, J., Moghoofei, M., Alvandi, A. H., Abiri, R.
10.1101/2021.01.23.427885 — Posted: 2021-01-24
In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface
Villoutreix, B., Calvez, V., Marcelin, A.-G., Khatib, A.-M.
10.1101/2021.01.24.427939 — Posted: 2021-01-24
Artificial Intelligence for Emotion-Semantic Trending and People Emotion Detection During COVID-19 Social Isolation
Jelodar, H., Orji, R., Matwin, S., Weerasinghe, S., Oyebode, O., Wang, Y.
10.1101/2021.01.16.21249943 — Posted: 2021-01-24
CD8+ T cell epitope variations suggest a potential antigen presentation deficiency for spike protein of SARS-CoV-2
Qiu, C., Xiao, C., Wang, Z., Zhu, G., Chen, X., Gao, L., Den, J., Su, J., Su, H., Fang, E. F., Zhang, Z., Zhang, J., Luo, O. J., Wang, P., Chen, G.
10.1101/2021.01.22.427863 — Posted: 2021-01-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).